← Study Library
In vitro · 2025
Preclinicalcounts toward this tierThe Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic Retinopathy
Gatta M, Dovizio M, Milillo C, Ruggieri AG, Sallese M, Antonucci I, Trofimov A, Khavinson V, Trofimova S, Bruno A, Ballerini P · Stem Cell Rev Rep
Preclinicalcounts toward this tier
High glucose slowed scratch-wound closure over 48 hours and raised hydrogen peroxide generation. Epitalon restored wound closure at all three concentrations, cut hydrogen peroxide at 40 and 60 ng/ml, and reversed the fall in antioxidant gene expression and the rise in epithelial-mesenchymal-transition and fibrosis markers.
- Population
- The human retinal pigment epithelial cell line ARPE-19 injured with high glucose (35 mM) as a model of diabetic retinopathy
- Intervention
- Epitalon 20, 40 or 60 ng/ml, supplied by the originating institute
- Comparator
- High-glucose cells without the peptide, and normal-glucose controls
- Limitations
- One immortalised cell line. A University of Chieti-Pescara collaboration with two institute authors, one of them Khavinson, who died before submission, and the peptide supplied by the institute; funded by the European Union's Next Generation EU national recovery plan; no competing interests declared.
Cited by
1 entry references this study
- EpithalonANECD.
Peptides → Preclinical & experimental
Evidence for that entry
Anecdotal